Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

3521. Population screening for abdominal aortic aneurysm: do the benefits outweigh the costs?

Population screening for abdominal aortic aneurysm: do the benefits outweigh the costs? Population screening for abdominal aortic aneurysm: do the benefits outweigh the costs? Population screening for abdominal aortic aneurysm: do the benefits outweigh the costs? Mason J M, Wakeman A P, Drummond M F, Crump B J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Ultrasound screening for abdominal aortic aneurysm (AAA). Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis. Study population Two identical, hypothetical cohorts (2000 in each) of men aged 70 years. Setting Primary care. The economic study was carried out in UK. Dates to which data relate The effectiveness analysis is mainly based

1993 NHS Economic Evaluation Database.

3522. Randomised controlled trial of Doppler ultrasound screening of placental perfusion during pregnancy. (Abstract)

Randomised controlled trial of Doppler ultrasound screening of placental perfusion during pregnancy. We have done a randomised controlled trial to assess the effect on primary management and outcome of routine doppler ultrasound examinations of the umbilical and uterine arteries during pregnancy. Over 9 months, 2600 women with singleton pregnancies were recruited from a general obstetric population. Of 2475 women who delivered in hospital after 20 weeks' gestation, 1246 had been allocated (...) of delivery, frequency of deliveries with fetal distress, or need for resuscitation or admission to the neonatal intensive care unit. More perinatal deaths occurred in the doppler group (17 vs 7, relative risk 2.4, 95% Cl 1.00-5.76), but only 1 of 11 normally formed stillbirths and none of the 4 normally formed neonatal deaths after 24 weeks' gestation had an abnormal umbilical-artery doppler examination. We did not demonstrate any improvement in neonatal outcome by routine doppler ultrasound screening

1992 Lancet Controlled trial quality: predicted high

3523. Computer-based interview for screening blood donors for risk of HIV transmission. (Abstract)

Computer-based interview for screening blood donors for risk of HIV transmission. To test the ability of a computer-based interview to detect factors related to the risk of the human immunodeficiency virus (HIV) among potential blood donors and to determine donor reactions to the use of the interview.A comparison of the rate of detection of HIV-related factors elicited by a computer interview with that obtained by standard American Red Cross procedures for assessment of donor suitability (...) Cross written questionnaires and face-to-face interviews were used for donor assessment.The interview took an average of 8 minutes to complete. From among 272 donors who provided complete data, the computer identified 12 donors who reported either behaviors associated with a risk of HIV acquisition or symptoms compatible with the acquired immunodeficiency syndrome; none of these donors had been so identified either by routine written questionnaires or by face-to-face interviews used to screen

1992 JAMA Controlled trial quality: uncertain

3524. Recruitment methods for screening programmes: trial of a new method within a regional osteoporosis study. Full Text available with Trip Pro

Recruitment methods for screening programmes: trial of a new method within a regional osteoporosis study. To estimate the response rates and operating costs of three recruitment methods within a regional osteoporosis screening programme.Randomised trial of three types of invitation letter: one offering fixed appointments with option to change time, one offering fixed appointments but requiring telephoned confirmation of intention to attend, and one inviting recipient to telephone to make (...) an appointment.Osteoporosis screening unit, Aberdeen.1200 women aged 45-49 years living within 32 km of Aberdeen and randomly selected from the community health index. 400 women were randomised to each appointment method.Numbers attending for screening; default rate among women who confirmed appointments; social class of attenders; cost per appointment slot and per completed scan.299 (75%), 277 (69%), and 217 (54%) women were scanned after fixed, confirmable, and open invitations respectively. Women who attended were

1992 BMJ Controlled trial quality: uncertain

3525. Screening for osteoporosis to prevent fractures

Screening for osteoporosis to prevent fractures Screening for osteoporosis to prevent fractures Screening for osteoporosis to prevent fractures NHS Centre for Reviews and Dissemination Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NHS Centre for Reviews and Dissemination. Screening for osteoporosis to prevent fractures. University (...) of York. Effective Health Care 1(1). 1992 Authors' objectives To assess whether a population-based screening programme for menopausal women with the aim of preventing fractures in elderly women should be established. Authors' conclusions It would be inadvisable to establish a routine population-based bone screening programme for menopausal women with the aim of preventing fractures. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Absorptiometry, Photon; Bone density; Estrogen

1992 Health Technology Assessment (HTA) Database.

3526. An overview of major breast screening studies and their findings

An overview of major breast screening studies and their findings An overview of major breast screening studies and their findings An overview of major breast screening studies and their findings Comis J, To T Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Comis J, To T. An overview of major breast screening studies and their findings (...) . Ottawa: Canadian Coordinating Office for Health Technology Assessment/Office Canadien de Coordination de l'Evaluation des Technologues de la Sante (CCOHTA) 1992: 52 (English), 51 (French) Authors' objectives To summarize findings reported by breast cancer screening studies, and to evaluate the impact of screening on incidence and mortality. Authors' conclusions Conclusive demonstration of the effects of a screening programme must await large studies which are underway, with long-term follow-up

1992 Health Technology Assessment (HTA) Database.

3527. Filtering strategies in mass population screening for colorectal cancer: an economic evaluation

Filtering strategies in mass population screening for colorectal cancer: an economic evaluation Filtering strategies in mass population screening for colorectal cancer: an economic evaluation Filtering strategies in mass population screening for colorectal cancer: an economic evaluation Walker A, Whynes D K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of mass population filtering strategies for the selection of individuals requiring further screening (colonoscopic investigation) for the detection of colorectal cancer (CRC). The strategies examined were as follows. Strategy 1: the Hemoccult faecal occult blood (FOB) test. A 3-day test, with no subsequent retesting of positives or negatives. Strategy 2: the Hemoccult

1992 NHS Economic Evaluation Database.

3528. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project

Antenatal maternal serum screening for Down's syndrome: results of a demonstration project Antenatal maternal serum screening for Down's syndrome: results of a demonstration project Antenatal maternal serum screening for Down's syndrome: results of a demonstration project Wald N J, Kennard A, Densem J W, Cuckle H S, Chard T, Butler L Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening test for Down's syndrome based on measurement of alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotrophin in maternal blood (Triple test). Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Women with singleton pregnancies between 15 to 22 weeks gestation from deprived

1992 NHS Economic Evaluation Database.

3529. Recruitment methods for screening programmes: trial of a new method within a regional osteoporosis study

Recruitment methods for screening programmes: trial of a new method within a regional osteoporosis study Recruitment methods for screening programmes: trial of a new method within a regional osteoporosis study Recruitment methods for screening programmes: trial of a new method within a regional osteoporosis study Garton M J, Torgerson D J, Donaldson C, Russell I T, Ried D M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each (...) abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Recruitment for screening for osteoporosis Type of intervention Screening Economic study type Cost-effectiveness analysis Study population Women aged 45-49 years Setting Osteoporosis screening unit (primary care). The economic study was carried out in Aberdeen, U. K. Dates to which data relate Effectiveness

1992 NHS Economic Evaluation Database.

3530. Systolic Hypertension in the Elderly Program (SHEP). Part 2: Screening and recruitment. (Abstract)

Systolic Hypertension in the Elderly Program (SHEP). Part 2: Screening and recruitment. 1999371 1991 04 09 2016 07 26 0194-911X 17 3 Suppl 1991 Mar Hypertension (Dallas, Tex. : 1979) Hypertension Systolic Hypertension in the Elderly Program (SHEP). Part 2: Screening and recruitment. II16-23 Petrovitch H H Byington R R Bailey G G Borhani P P Carmody S S Goodwin L L Harrington J J Johnson H A HA Johnson P P Jones M M eng Clinical Trial Journal Article Multicenter Study Randomized Controlled Trial (...) United States Hypertension 7906255 0194-911X IM Decision Making Health Services Needs and Demand Health Services for the Aged Humans Hypertension epidemiology therapy Mass Screening Research Design Systole United States epidemiology 1991 3 1 1991 3 1 0 1 1991 3 1 0 0 ppublish 1999371

1991 Hypertension (Dallas, Tex. : 1979) Controlled trial quality: uncertain

3531. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. Imperial Cancer Research Fund OXCHECK Study Group. Full Text available with Trip Pro

Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. Imperial Cancer Research Fund OXCHECK Study Group. To describe the outcome of offering health checks systematically to a general practice adult population, in terms of age and sex specific prevalence of risk factors, follow up workload, and selective screening of cholesterol concentration.Descriptive analysis of data obtained by postal questionnaire and by personal interview and clinical (...) % of women. The total cholesterol concentration was greater than or equal to 6.5 mmol/l in 37% of patients and greater than or equal to 8 mmol/l in 8%. In terms of workload 13% needed dietary advice only, 15% needed only follow up of hyperlipidaemia or hypertension, and 9% needed advice on smoking only. A further 35% needed follow up for a combination of risk factors. The proportion of patients in whom cholesterol concentration would be measured if a selective screening policy were adopted would vary

1991 BMJ Controlled trial quality: uncertain

3532. Capacity of HIV1 p24 antigen screening to reduce the current residual risk of contracting HIV infection following transfusion

Capacity of HIV1 p24 antigen screening to reduce the current residual risk of contracting HIV infection following transfusion Capacity of HIV1 p24 antigen screening to reduce the current residual risk of contracting HIV infection following transfusion Capacity of HIV1 p24 antigen screening to reduce the current residual risk of contracting HIV infection following transfusion Fleurette F, Durieux, P Record Status This is a bibliographic record of a published health technology assessment from (...) a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Fleurette F, Durieux, P. Capacity of HIV1 p24 antigen screening to reduce the current residual risk of contracting HIV infection following transfusion. Paris: L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) 1991: 20 Authors' objectives Given that a screening procedure to detect Human Immunodeficiency Virus (HIV) itself rather than the immune response, was made available

1991 Health Technology Assessment (HTA) Database.

3533. Evaluation of screening tests to prevent transfusion-associated non-A non-B hepatitis

Evaluation of screening tests to prevent transfusion-associated non-A non-B hepatitis Evaluation of screening tests to prevent transfusion-associated non-A non-B hepatitis Evaluation of screening tests to prevent transfusion-associated non-A non-B hepatitis Fleurette F, Durieux P Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Fleurette F (...) , Durieux P. Evaluation of screening tests to prevent transfusion-associated non-A non-B hepatitis. Paris: L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) 1991: 63 Authors' objectives To determine the optimal prevention strategy for transfusion associated non-A non-B hepatitis at the request of the French Department of Health. The expert panel defined the following issues: frequency of transfusion-associated non-A non-B hepatitis, clinical course of the disease, efficacy of surrogate

1991 Health Technology Assessment (HTA) Database.

3534. An annotated bibliography of the costs and benefits of prenatal screening programs

An annotated bibliography of the costs and benefits of prenatal screening programs An annotated bibliography of the costs and benefits of prenatal screening programs An annotated bibliography of the costs and benefits of prenatal screening programs Comis J, Conlon J Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Comis J, Conlon J (...) . An annotated bibliography of the costs and benefits of prenatal screening programs. Ottawa: Canadian Coordinating Office for Health Technology Assessment/Office Canadien de Coordination de l'Evaluation des Technologues de la Sante (CCOHTA) 1991: 67 (English), 58 (French) Authors' objectives To ascertain the current state of knowledge regarding costs and benefits of prenatal screening programs. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Genetic Screening; Prenatal Care /diagnosis

1991 Health Technology Assessment (HTA) Database.

3535. Economic analysis of screening for breast cancer: report for Scottish Home and Health Department

Economic analysis of screening for breast cancer: report for Scottish Home and Health Department Economic analysis of screening for breast cancer: report for Scottish Home and Health Department Economic analysis of screening for breast cancer: report for Scottish Home and Health Department Clarke P R, Fraser N M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Mammography and clinical examination. Type of intervention Screening and treatment. Economic study type Cost-effectiveness analysis and cost-utility analysis. Study population Women aged 45 to 65. Setting The study was carried out in the United Kingdom. Dates to which data relate Price related to 1989. Source of effectiveness data Single study. Study sample There is evidence

1991 NHS Economic Evaluation Database.

3536. Screening the elderly in the community: controlled trial of dependency surveillance using a questionnaire administered by volunteers. Full Text available with Trip Pro

Screening the elderly in the community: controlled trial of dependency surveillance using a questionnaire administered by volunteers. To test the benefits of regular surveillance of the elderly at home using an activities of daily living questionnaire administered by volunteers.Randomised controlled study.539 Subjects aged 75 and over from two general practices.All subjects were visited at the beginning and end of the study by volunteers, who completed a scored activity of daily living

1990 BMJ Controlled trial quality: uncertain

3537. Locomotor disability in very elderly people: value of a programme for screening and provision of aids for daily living. Full Text available with Trip Pro

Locomotor disability in very elderly people: value of a programme for screening and provision of aids for daily living. To assess the prevalence of potentially reversible locomotor disabilities in elderly subjects and the cost effectiveness of providing aids for daily living.Population based randomised controlled trial of subjects aged greater than or equal to 85 living independently in an inner London borough.21 Electoral wards of the London Borough of Hackney.1255 Subjects aged greater than (...) or equal to 85 living in their own home whose names were obtained from general practitioner lists and cross checked against the electoral register, 511 of whom were subsequently found to be ineligible. Of the 744 remaining, those with disability on screening were randomised and allocated to an intervention group (36) or a control group (43), in which intervention was postponed until four weeks, after the follow up assessment. Subjects with aids supplied previously were excluded from the intervention

1990 BMJ Controlled trial quality: uncertain

3538. Edinburgh trial of screening for breast cancer: mortality at seven years. (Abstract)

Edinburgh trial of screening for breast cancer: mortality at seven years. Between 1979 and 1981, 45,130 women in Edinburgh aged 45-64 were entered into a randomised trial of breast cancer screening by mammography and clinical examination. The initial attendance rate was 61% but this varied according to age and socioeconomic status and decreased over succeeding years. The cancer detection rate was 6.2 per 1000 women attending at the first visit; the rate fell to around 3 per 1000 in the years (...) when mammography was routinely repeated and to around 1 per 1000 at the intervening visits with clinical examination alone as the screening method. After 7 years of follow-up the mortality reduction achieved was 17% (relative risk = 0.83, 95% CI 0.58-1.18), which was not statistically significant, even when corrected for socioeconomic status. In women aged 50 years and over a mortality reduction of 20% was achieved.

1990 Lancet Controlled trial quality: uncertain

3539. Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. (Abstract)

Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. During a 19-month period, 95% of all pregnant women in the greater Helsinki area, Finland, entered a study to compare one-stage ultrasonography screening with selective screening according to antenatal hospital use, obstetric procedures, and fetal outcomes. Of 9310 women who entered the trial, 4691 were randomly allocated to ultrasound screening between (...) the 16th and 20th gestational weeks and 4619 to follow-up only. Screened and control groups otherwise had the same antenatal care, which included ultrasonography according to usual practice. Screened women made fewer visits to the antenatal outpatient clinic than did women in the control group (2.3 vs 2.6). There were no differences in the number of labour inductions or mean birthweights in the two groups. Perinatal mortality was significantly lower in the screened than in the control group (4.6/1000

1990 Lancet Controlled trial quality: uncertain

3540. Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy

Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy Cost effectiveness of screening perimenopausal white women for osteoporosis: bone densitometry and hormone replacement therapy Tosteson A N, Rosenthal D I, Melton J, Weinstein M C Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Hormone replacement therapy (progesterone and oestrogen). Type of intervention Screening. Economic study type Cost-effectiveness analysis and cost-utility analysis. Study population Women with bone density <0.9g2 and women with bone density

1990 NHS Economic Evaluation Database.